Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

Serum carbohydrate antigen 19-9 (CA 19-9) has been identified as a useful tumour marker for diagnosis of exocrine pancreatic carcinoma, but its value for evaluating the response to chemotherapy with gemcitabine is not clear. Tumour regression in pancreatic carcinoma is hard to determine due to massi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziske, C, Schlie, C, Gorschlüter, M, Glasmacher, A, Mey, U, Strehl, J, Sauerbruch, T, Schmidt-Wolf, I G H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394360/
https://www.ncbi.nlm.nih.gov/pubmed/14562009
http://dx.doi.org/10.1038/sj.bjc.6601263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394360/
https://www.ncbi.nlm.nih.gov/pubmed/14562009
http://dx.doi.org/10.1038/sj.bjc.6601263

Ejemplares similares